First Time Loading...
O

OmniAb Inc
NASDAQ:OABI

Watchlist Manager
OmniAb Inc
NASDAQ:OABI
Watchlist
Price: 4.57 USD 0.66% Market Closed
Updated: May 10, 2024

Intrinsic Value

OABI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

OmniAb, Inc. operates as a drug discovery company. [ Read More ]

The intrinsic value of one OABI stock under the Base Case scenario is 4.45 USD. Compared to the current market price of 4.57 USD, OmniAb Inc is Overvalued by 3%.

Key Points:
OABI Intrinsic Value
Base Case
4.45 USD
Overvaluation 3%
Intrinsic Value
Price
O
Worst Case
Base Case
Best Case

Valuation Backtest
OmniAb Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling OABI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
OmniAb Inc

Provide an overview of the primary business activities
of OmniAb Inc.

What unique competitive advantages
does OmniAb Inc hold over its rivals?

What risks and challenges
does OmniAb Inc face in the near future?

Has there been any significant insider trading activity
in OmniAb Inc recently?

Summarize the latest earnings call
of OmniAb Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for OmniAb Inc.

Provide P/S
for OmniAb Inc.

Provide P/E
for OmniAb Inc.

Provide P/OCF
for OmniAb Inc.

Provide P/FCFE
for OmniAb Inc.

Provide P/B
for OmniAb Inc.

Provide EV/S
for OmniAb Inc.

Provide EV/GP
for OmniAb Inc.

Provide EV/EBITDA
for OmniAb Inc.

Provide EV/EBIT
for OmniAb Inc.

Provide EV/OCF
for OmniAb Inc.

Provide EV/FCFF
for OmniAb Inc.

Provide EV/IC
for OmniAb Inc.

Show me price targets
for OmniAb Inc made by professional analysts.

What are the Revenue projections
for OmniAb Inc?

How accurate were the past Revenue estimates
for OmniAb Inc?

What are the Net Income projections
for OmniAb Inc?

How accurate were the past Net Income estimates
for OmniAb Inc?

What are the EPS projections
for OmniAb Inc?

How accurate were the past EPS estimates
for OmniAb Inc?

What are the EBIT projections
for OmniAb Inc?

How accurate were the past EBIT estimates
for OmniAb Inc?

Compare the revenue forecasts
for OmniAb Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of OmniAb Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of OmniAb Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of OmniAb Inc compared to its peers.

Compare the P/E ratios
of OmniAb Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing OmniAb Inc with its peers.

Analyze the financial leverage
of OmniAb Inc compared to its main competitors.

Show all profitability ratios
for OmniAb Inc.

Provide ROE
for OmniAb Inc.

Provide ROA
for OmniAb Inc.

Provide ROIC
for OmniAb Inc.

Provide ROCE
for OmniAb Inc.

Provide Gross Margin
for OmniAb Inc.

Provide Operating Margin
for OmniAb Inc.

Provide Net Margin
for OmniAb Inc.

Provide FCF Margin
for OmniAb Inc.

Show all solvency ratios
for OmniAb Inc.

Provide D/E Ratio
for OmniAb Inc.

Provide D/A Ratio
for OmniAb Inc.

Provide Interest Coverage Ratio
for OmniAb Inc.

Provide Altman Z-Score Ratio
for OmniAb Inc.

Provide Quick Ratio
for OmniAb Inc.

Provide Current Ratio
for OmniAb Inc.

Provide Cash Ratio
for OmniAb Inc.

What is the historical Revenue growth
over the last 5 years for OmniAb Inc?

What is the historical Net Income growth
over the last 5 years for OmniAb Inc?

What is the current Free Cash Flow
of OmniAb Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for OmniAb Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
OmniAb Inc

Current Assets 94.9m
Cash & Short-Term Investments 87m
Receivables 3.8m
Other Current Assets 4.1m
Non-Current Assets 280.3m
PP&E 38.1m
Intangibles 239.4m
Other Non-Current Assets 2.7m
Current Liabilities 23.1m
Accounts Payable 4.4m
Accrued Liabilities 9.3m
Other Current Liabilities 9.4m
Non-Current Liabilities 37.5m
Other Non-Current Liabilities 37.5m
Efficiency

Earnings Waterfall
OmniAb Inc

Revenue
34.2m USD
Operating Expenses
-103.6m USD
Operating Income
-69.4m USD
Other Expenses
18.8m USD
Net Income
-50.6m USD

Free Cash Flow Analysis
OmniAb Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

OABI Profitability Score
Profitability Due Diligence

OmniAb Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative ROE
Negative ROIC
25/100
Profitability
Score

OmniAb Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

OABI Solvency Score
Solvency Due Diligence

OmniAb Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

OmniAb Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OABI Price Targets Summary
OmniAb Inc

Wall Street analysts forecast OABI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OABI is 10.2 USD with a low forecast of 7.07 USD and a high forecast of 13.65 USD.

Lowest
Price Target
7.07 USD
55% Upside
Average
Price Target
10.2 USD
123% Upside
Highest
Price Target
13.65 USD
199% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

OABI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

OABI Price
OmniAb Inc

1M 1M
-13%
6M 6M
+8%
1Y 1Y
+38%
3Y 3Y
-35%
5Y 5Y
-35%
10Y 10Y
-35%
Annual Price Range
4.57
52w Low
3.23
52w High
6.69
Price Metrics
Average Annual Return -50.43%
Standard Deviation of Annual Returns
N/A
Max Drawdown -71%
Shares Statistics
Market Capitalization 534m USD
Shares Outstanding 117 606 000
Percentage of Shares Shorted 6.6%

OABI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

OmniAb Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

534m USD

Dividend Yield

0%

Description

OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 93 full-time employees. The company went IPO on 2020-10-09. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. Its OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach and OmniTaur features structural attributes of cow antibodies for complex targets. The firm's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic targets.

Contact

CALIFORNIA
Emeryville
5980 Horton Street, Suite 600
+15102507800
https://www.omniab.com/

IPO

2020-10-09

Employees

93

Officers

President, CEO & Director
Mr. Matthew W. Foehr
Executive VP of Finance & CFO
Mr. Kurt A. Gustafson
Chief Legal Officer & Secretary
Mr. Charles S. Berkman J.D.
Vice President of People & Talent
Ms. Cia McCaffrey
Senior Vice President of Antibody Discovery
Dr. Bill Harriman Ph.D.
Senior Vice President of Technical Operations & Genetics
Ms. Marie-Cecile van de Lavoir D.V.M., Ph.D.
Show More
Senior Vice President of Antibody Technologies
Dr. Christel Iffland Ph.D.
Senior VP of Ion Channels/Transporters & Icagen Ion Channel Technology Site Head
Dr. Douglas S. Krafte Ph.D.
Senior Vice President of Corporate Controller
Ms. Donna Ventura CPA
Show Less

See Also

Discover More
What is the Intrinsic Value of one OABI stock?

The intrinsic value of one OABI stock under the Base Case scenario is 4.45 USD.

Is OABI stock undervalued or overvalued?

Compared to the current market price of 4.57 USD, OmniAb Inc is Overvalued by 3%.